Startups
ApoGlyx

A virtual biotech company focused on developing oral therapy for type 2 diabetes patients in the pre-clinical stage.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Seedtable Score

Score icon 15

Locations

Company Size

  • 1 to 10

Last Stage Round

Industry

Insights

Total Funding
$700k
Investors